La Roche and Spark announce withdrawal and refiling of Premerger Notification and Report Form under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement.
Featured News
Dutch Court Upholds Antitrust Ruling Against Apple Over App Store Practices
Jun 16, 2025 by
CPI
South Korea Launches Antitrust Probe Into Egg Producers Over Price Hike Allegations
Jun 16, 2025 by
CPI
Italy Opens Antitrust Probe into Chinese AI Firm DeepSeek
Jun 16, 2025 by
CPI
China Clears $8.2 Billion Bunge-Viterra Merger
Jun 16, 2025 by
CPI
UK Competition Watchdog Eyes Potential Evri-DHL Merger Over Market Concerns
Jun 16, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Industrial Policy
May 21, 2025 by
CPI
Industrial Strategy and the Role of Competition – Taking a Business Lens
May 21, 2025 by
Marcus Bokkerink
Industrial Policy, Antitrust, and Economic Growth: Some Observations
May 21, 2025 by
David S. Evans
Bolder by Design: Crafting Pro-Competitive Industrial Policies For Complex Challenges
May 21, 2025 by
Antonio Capobianco & Beatriz Marques
Competition-Friendly Industrial Policy
May 21, 2025 by
Philippe Aghion, Mathias Dewatripont & Patrick Legros